Literature DB >> 9002149

Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children.

J P Couetil1, O Soubrane, D P Houssin, B E Dousset, P G Chevalier, A Guinvarch, D Loulmet, A Achkar, A F Carpentier.   

Abstract

Between June 1990 and September 1995, 8 of 24 children with cystic fibrosis (CF) who were accepted either for combined transplantation or isolated liver transplantation died while waiting for a graft; 11 underwent transplantation and 5 are currently on the waiting list. Of the 11 children who had surgery, 7 (group 1) underwent one of the following procedures: heart-lung-liver (n = 4), sequential double lung-liver (n = 2), or bilateral lobar lung from a split left lung and reduced liver (n = 1). During the same period, the four other children (group 2) underwent isolated liver transplantation (three full-size livers, one partial liver). There was one perioperative death in each group. Pulmonary infection was the most common cause of morbidity in group 1. Other complications in group 1 included tracheobronchial stenosis (n = 2), biliary stricture (n = 2), and severe ascites (n = 2). All were successfully treated. Obliterative bronchiolitis developed in three patients. This was treated with FK 506. In group 2, pulmonary function tests improved or remained stable after liver transplantation. Surgical complications in group 2 included severe ascites (n = 1), biliary stricture (n = 1), and abscess of the liver (n = 1). Actuarial survival was 85.7% +/- 2% in group 1 at 1 year; it remained unchanged at 3 years and was 64.2% at 5 years.

Entities:  

Mesh:

Year:  1997        PMID: 9002149     DOI: 10.1007/bf02044339

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Liver involvement in cystic fibrosis.

Authors:  Catherine Brigman; Andrew Feranchak
Journal:  Curr Treat Options Gastroenterol       Date:  2006

3.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

Review 4.  Management of portopulmonary hypertension: new perspectives.

Authors:  Luigi Mancuso; Francesca Scordato; Michela Pieri; Eliana Valerio; Andrea Mancuso
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 5.  Managing liver failure.

Authors:  D A Kelly
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

6.  The cost-effectiveness of neonatal screening for cystic fibrosis: an analysis of alternative scenarios using a decision model.

Authors:  Neil Simpson; Rob Anderson; Franco Sassi; Alexandra Pitman; Peter Lewis; Karen Tu; Heather Lannin
Journal:  Cost Eff Resour Alloc       Date:  2005-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.